Page last updated: 2024-10-30

metaproterenol and Respiration Disorders

metaproterenol has been researched along with Respiration Disorders in 2 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LICHTERFELD, A1
Borrello, G1
Quarta, E1

Other Studies

2 other studies available for metaproterenol and Respiration Disorders

ArticleYear
[Spirometric research on the comparison of the effect of Alupent and Aludrin aerosols in obstructive ventilation disorders].
    Die Medizinische Welt, 1961, Dec-30, Volume: 52

    Topics: Aerosols; Disease; Humans; Metaproterenol; Respiration; Respiration Disorders; Respiratory System; R

1961
[Atrio-ventricular dissociation with diaphragmatic flutter in man. Esophageal electrocardiogrpahic study].
    Bollettino della Societa italiana di cardiologia, 1977, Volume: 22, Issue:2

    Topics: Atrial Flutter; Diagnosis, Differential; Diaphragm; Electrocardiography; Heart Block; Humans; Metapr

1977